Goldman Sachs’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$601K Sell
484,741
-1,379,742
-74% -$1.71M ﹤0.01% 4162
2025
Q1
$2.2M Sell
1,864,483
-2,928,293
-61% -$3.46M ﹤0.01% 3304
2024
Q4
$8.77M Buy
4,792,776
+554,509
+13% +$1.01M ﹤0.01% 2433
2024
Q3
$7.21M Buy
4,238,267
+255,702
+6% +$435K ﹤0.01% 2501
2024
Q2
$5.46M Buy
3,982,565
+1,776,559
+81% +$2.43M ﹤0.01% 2544
2024
Q1
$8.27M Buy
2,206,006
+614,899
+39% +$2.31M ﹤0.01% 2201
2023
Q4
$15.6M Sell
1,591,107
-102,286
-6% -$1M ﹤0.01% 1754
2023
Q3
$14.1M Sell
1,693,393
-768,448
-31% -$6.42M ﹤0.01% 1733
2023
Q2
$32.7M Buy
2,461,841
+142,549
+6% +$1.9M 0.01% 1203
2023
Q1
$26.9M Sell
2,319,292
-220,869
-9% -$2.56M 0.01% 1307
2022
Q4
$20.8M Sell
2,540,161
-1,115,284
-31% -$9.12M 0.01% 1583
2022
Q3
$21.2M Sell
3,655,445
-4,783,127
-57% -$27.8M 0.01% 1550
2022
Q2
$37.3M Buy
8,438,572
+5,533,953
+191% +$24.5M 0.01% 1153
2022
Q1
$26.4M Buy
2,904,619
+228,964
+9% +$2.08M 0.01% 1526
2021
Q4
$54.7M Buy
2,675,655
+309,978
+13% +$6.34M 0.01% 1066
2021
Q3
$60.4M Sell
2,365,677
-263,165
-10% -$6.72M 0.01% 974
2021
Q2
$91.9M Buy
2,628,842
+1,410,554
+116% +$49.3M 0.02% 686
2021
Q1
$40.6M Buy
1,218,288
+948,644
+352% +$31.6M 0.01% 1170
2020
Q4
$7M Sell
269,644
-146,619
-35% -$3.8M ﹤0.01% 2265
2020
Q3
$4.11M Sell
416,263
-501,978
-55% -$4.95M ﹤0.01% 2501
2020
Q2
$3.17M Sell
918,241
-1,696,594
-65% -$5.85M ﹤0.01% 2591
2020
Q1
$8M Sell
2,614,835
-587,288
-18% -$1.8M ﹤0.01% 1936
2019
Q4
$16.5M Sell
3,202,123
-19,827
-0.6% -$102K ﹤0.01% 1742
2019
Q3
$16.6M Sell
3,221,950
-2,075,410
-39% -$10.7M ﹤0.01% 1640
2019
Q2
$32M Buy
5,297,360
+2,437,877
+85% +$14.7M 0.01% 1294
2019
Q1
$20.7M Buy
2,859,483
+204,228
+8% +$1.48M 0.01% 1591
2018
Q4
$19.6M Buy
2,655,255
+2,435,703
+1,109% +$18M 0.01% 1534
2018
Q3
$1.19M Buy
219,552
+60,234
+38% +$326K ﹤0.01% 3111
2018
Q2
$566K Sell
159,318
-79,482
-33% -$282K ﹤0.01% 3470
2018
Q1
$490K Buy
238,800
+86,393
+57% +$177K ﹤0.01% 3507
2017
Q4
$402K Buy
152,407
+13,431
+10% +$35.4K ﹤0.01% 3545
2017
Q3
$729K Sell
138,976
-11,079
-7% -$58.1K ﹤0.01% 3366
2017
Q2
$534K Buy
150,055
+29,192
+24% +$104K ﹤0.01% 3505
2017
Q1
$625K Sell
120,863
-120,046
-50% -$621K ﹤0.01% 3388
2016
Q4
$915K Buy
240,909
+56,524
+31% +$215K ﹤0.01% 3139
2016
Q3
$1.65M Buy
184,385
+109,493
+146% +$981K ﹤0.01% 2804
2016
Q2
$527K Buy
74,892
+6,605
+10% +$46.5K ﹤0.01% 3292
2016
Q1
$580K Sell
68,287
-111,469
-62% -$947K ﹤0.01% 3143
2015
Q4
$2.36M Buy
179,756
+120,600
+204% +$1.58M ﹤0.01% 2433
2015
Q3
$217K Sell
59,156
-26,429
-31% -$96.9K ﹤0.01% 3822
2015
Q2
$493K Buy
85,585
+13,864
+19% +$79.9K ﹤0.01% 3367
2015
Q1
$419K Buy
71,721
+26,091
+57% +$152K ﹤0.01% 3430
2014
Q4
$358K Sell
45,630
-337,883
-88% -$2.65M ﹤0.01% 3583
2014
Q3
$1.88M Buy
383,513
+321,202
+515% +$1.58M ﹤0.01% 2551
2014
Q2
$385K Buy
62,311
+31,649
+103% +$196K ﹤0.01% 3513
2014
Q1
$164K Buy
30,662
+18,483
+152% +$98.9K ﹤0.01% 4020
2013
Q4
$64K Buy
12,179
+1,207
+11% +$6.34K ﹤0.01% 4148
2013
Q3
$61K Buy
+10,972
New +$61K ﹤0.01% 4083